PharmaEssentia Corporation
6446
Rangering i aksjer
#1418
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Aksjekurs
$37.84
Sist synkronisert: 2026-10-19
Markedsverdi
$15.65B
Endring (1 dag)
-4.42%
Endring (1 år)
150.43%
Land
TW
Handel PharmaEssentia Corporation (6446)
Kategori
Healthcare
Utbyttehistorikk for PharmaEssentia Corporation (6446)
PharmaEssentia Corporation (aksjesymbol: 6446) har gitt totalt 1 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $0.99
Utbytteavkastning (TTM): 0.0012
Summen av alle utbytter (justert for aksjesplitt): $0.99
Utbytteavkastning (TTM): 0.0012
Utbyttebetalinger for PharmaEssentia Corporation (6446) fra 2025 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.9898 | 0.00% |
| 2025 | $0.9898 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $1.10 | 0.00% |
| 2025 | $1.10 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
